Biology:Forkhead box L2
Generic protein structure example |
Forkhead box protein L2 is a protein that in humans is encoded by the FOXL2 gene.[1][2]
Function
FOXL2 is a forkhead transcription factor. The protein contains a fork-head DNA-binding domain and plays a role in ovarian development and function.[2] FoxL2 is a marker for ovarian differentiation, and is required for granulosa cell differentiation. In addition, the foxl2 protein will prevent the formation of testes by suppressing expression of SOX9.[3]
In postnatal ovaries FOXL2 regulates granulosa cell differentiation and also supports the growth of the pre-ovulatory follicles during adult life.[4]
Regulation
FOXL2 has several post-translational modifications that modulate its stability, subcellular localization and pro-apoptotic activity.[5] By a yeast-two-hybrid screening, 10 novel protein partners of FOXL2 are discovered. The interactions were confirmed by co-immunoprecipitation experiments between FOXL2 and CXXC4 (IDAX), CXXC5 (RINF/WID), CREM, GMEB1 (P96PIF), NR2C1 (TR2), SP100, RPLP1, BAF (BANF1), XRCC6 (KU70) and SIRT1.[6]
Clinical significance
Sex determination
This protein is involved in sex determination. Female missing the FOXL2 gene appear male. FOXL2 knockout in mature mouse ovaries cause them to develop into testes, however oocytes are still formed.[7]
Blepharophimosis-ptosis-epicanthus inversus syndrome
Mutations in this gene are a cause of blepharophimosis syndrome and/or premature ovarian failure 3.[2] Predicting the occurrence of POF based on the nature of the missense mutations in FOXL2 was a medical challenge. However, a correlation between the transcriptional activity of FOXL2 variants and the type of BPES has been founded.[8] Moreover by studying the effects of natural and artificial mutations in the forkhead domain of FOXL2, a clear correlation between the orientation of amino-acid side chains in the DNA-binding domain and transcriptional activity is founded, providing the first (in silico) predictive tool of the effects of FOXL2 missense mutations.[9]
Adult Granulosa Cell Tumors AGCT
A missense mutation in the FOXL2 gene C134W is found in adult granulosa cell tumors, but not in other ovarian cancers nor in juvenile granulosa cell tumors.[4]
Endometriosis
In addition to ovarian expression of FOXL2, there has been recent studies to suggest that overexpression of FOXL2 has been implicated in endometriosis in addition to activin A.[10]
Others Deregulations
One study has found that FOXL2 is required for SF-1-induced ovarian AMH regulation by interactions between FOXL2 protein and SF-1, a mutated FOXL2 could not interact with SF-1 normally and thus could not regulate ovarian AMH as normal.[11]
In a knockout study in mice, the granulosa cells of the ovaries failed to undergo the squamous-to-cuboidal transition which led to the arrest of folliculogenesis[12]
See also
References
- ↑ "Further evidence for the location of the BPES gene at 3q2". Journal of Medical Genetics 28 (10): 725. October 1991. doi:10.1136/jmg.28.10.725. PMID 1941972.
- ↑ 2.0 2.1 2.2 "Entrez Gene: FOXL2 forkhead box L2". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=668.
- ↑ "Sequential, Divergent, and Cooperative Requirements of Foxl2a and Foxl2b in Ovary Development and Maintenance of Zebrafish". Genetics 205 (4): 1551–1572. April 2017. doi:10.1534/genetics.116.199133. PMID 28193729.
- ↑ 4.0 4.1 "Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors". The International Journal of Biochemistry & Cell Biology 72: 51–4. March 2016. doi:10.1016/j.biocel.2016.01.003. PMID 26791928.
- ↑ "SUMOylation of the Forkhead transcription factor FOXL2 promotes its stabilization/activation through transient recruitment to PML bodies". PLOS ONE 6 (10): e25463. Oct 2011. doi:10.1371/journal.pone. PMID 22022399.
- ↑ "Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles". Human Molecular Genetics 21 (14): 3264–74. July 2012. doi:10.1093/hmg/dds170. PMID 22544055.
- ↑ "Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation". Cell 139 (6): 1130–42. December 2009. doi:10.1016/j.cell.2009.11.021. PMID 20005806. Lay summary – Nature News.
- ↑ "Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems". Human Molecular Genetics 18 (17): 3324–33. September 2009. doi:10.1093/hmg/ddp273. PMID 19515849.
- ↑ "Mutational probing of the forkhead domain of the transcription factor FOXL2 provides insights into the pathogenicity of naturally occurring mutations". Human Molecular Genetics 20 (17): 3376–85. September 2011. doi:10.1093/hmg/ddr244. PMID 21632871.
- ↑ "FOXL2 in human endometrium: hyperexpressed in endometriosis" (in en). Reproductive Sciences 21 (10): 1249–55. October 2014. doi:10.1177/1933719114522549. PMID 24520083.
- ↑ "FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Müllerian Hormone in Human Granulosa Cells". PLOS ONE 11 (7): e0159112. 2016-07-14. doi:10.1371/journal.pone.0159112. PMID 27414805.
- ↑ "The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance" (in en). Development 131 (4): 933–42. February 2004. doi:10.1242/dev.00969. PMID 14736745.
Further reading
- "High-resolution human/goat comparative map of the goat polled/intersex syndrome (PIS): the human homologue is contained in a human YAC from HSA3q23". Genomics 56 (1): 31–9. February 1999. doi:10.1006/geno.1998.5691. PMID 10036183.
- "Unified nomenclature for the winged helix/forkhead transcription factors". Genes & Development 14 (2): 142–6. January 2000. doi:10.1101/gad.14.2.142. PMID 10702024.
- "The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome". Nature Genetics 27 (2): 159–66. February 2001. doi:10.1038/84781. PMID 11175783.
- "Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation". Human Molecular Genetics 10 (15): 1591–600. July 2001. doi:10.1093/hmg/10.15.1591. PMID 11468277.
- "Identification of a new TWIST mutation (7p21) with variable eyelid manifestations supports locus homogeneity of BPES at 3q22". Journal of Medical Genetics 38 (7): 470–2. July 2001. doi:10.1136/jmg.38.7.470. PMID 11474656.
- "Heterozygous 17-bp deletion in the forkhead transcription factor gene, FOXL2, in a Japanese family with blepharophimosis-ptosis-epicanthus inversus syndrome". Journal of Human Genetics 46 (12): 733–6. 2002. doi:10.1007/s100380170009. PMID 11776388.
- "A novel mutation in the FOXL2 gene in a patient with blepharophimosis syndrome: differential role of the polyalanine tract in the development of the ovary and the eyelid". Ophthalmic Genetics 23 (1): 43–7. March 2002. doi:10.1076/opge.23.1.43.2202. PMID 11910558.
- "Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2". Genetic Testing 5 (4): 335–8. 2002. doi:10.1089/109065701753617499. PMID 11960581.
- "Identification of novel mutations in FOXL2 associated with premature ovarian failure". Molecular Human Reproduction 8 (8): 729–33. August 2002. doi:10.1093/molehr/8.8.729. PMID 12149404.
- "FOXL2 mutation screening in a large panel of POF patients and XX males". Journal of Medical Genetics 39 (8): e43. August 2002. doi:10.1136/jmg.39.8.e43. PMID 12161610.
- "Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families". American Journal of Medical Genetics 113 (1): 47–51. November 2002. doi:10.1002/ajmg.10741. PMID 12400065.
- "Evolution and expression of FOXL2". Journal of Medical Genetics 39 (12): 916–21. December 2002. doi:10.1136/jmg.39.12.916. PMID 12471206.
- "FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation". American Journal of Human Genetics 72 (2): 478–87. February 2003. doi:10.1086/346118. PMID 12529855.
- "Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells". FEBS Letters 535 (1–3): 6–10. January 2003. doi:10.1016/S0014-5793(02)03846-2. PMID 12560069.
- "FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES); challenges for genetic counseling in female patients". American Journal of Medical Genetics. Part A 117A (2): 143–6. March 2003. doi:10.1002/ajmg.a.10024. PMID 12567411.
- "Sporadic and familial blepharophimosis -ptosis-epicanthus inversus syndrome: FOXL2 mutation screen and MRI study of the superior levator eyelid muscle". Clinical Genetics 63 (2): 117–20. February 2003. doi:10.1034/j.1399-0004.2003.00011.x. PMID 12630957.
- "Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients". Human Mutation 22 (3): 222–8. September 2003. doi:10.1002/humu.10251. PMID 12938087.
- "FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences". Genomics 83 (5): 757–64. May 2004. doi:10.1016/j.ygeno.2003.11.010. PMID 15081106.
- "Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles". Human Molecular Genetics 21 (14): 3264–74. July 2012. doi:10.1093/hmg/dds170. PMID 22544055.
- "The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells". eLife 3. November 2014. doi:10.7554/eLife.04207. PMID 25369636.
- "The genetic make-up of ovarian development and function: the focus on the transcription factor FOXL2". Clinical Genetics 91 (2): 173–182. February 2017. doi:10.1111/cge.12862. PMID 27604691.
External links
- FOXL2+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
- GeneReviews/NCBI/NIH/UW entry on Blepharophimosis, Ptosis, and Epicanthus Inversus